Fluidigm China Opens Its Doors
News Apr 23, 2012
Through the establishment of a wholly-owned Fluidigm subsidiary in China in late January 2012, officially known as Fluidigm (Shanghai) Instrument Technology Co., Ltd., Fluidigm will improve services to its Chinese customer base and expects to rapidly build a strong presence in that country’s burgeoning life science research community.
“The establishment of our China subsidiary in this rapidly growing nation is an especially important commercial development for Fluidigm. We believe China will be an important growth driver for Fluidigm in 2012 and into the future,” said Gajus Worthington, president and chief executive officer of Fluidigm. “China is aggressively pursuing research in therapeutic stem cells and single-cell genomics. Customers in various Chinese universities, hospitals and government-sponsored laboratories are conducting world-class research in these areas of global importance and they need world-class tools to help them achieve their objectives. We believe Fluidigm nanofluidic technology brings the world’s most advanced single-cell and stem-cell solutions available in the world to the Chinese life science research community. We want to help our customers move forward in these critical areas of research as quickly as possible,” Worthington concluded.
“Over the years, we have sold and installed more than 20 instruments in China. Those systems are helping our customers conduct single-cell research, prepare samples for targeted sequencing experiments, and ensure the quality and safety of China’s food supply. This is a good beginning and we hope to contribute more capabilities to the Chinese research community in the future,” said Joanna Jiang, general manager of Fluidigm China. “While we now have a direct presence in China, we are a small company and will continue to work with our distribution partners to ensure that we can meet the needs of our customers throughout China’s vast geography.”
Fluidigm is the creator and world’s leading supplier of integrated fluidic circuits. Fluidigm microfluidic chips, systems, assays and other reagents enable genetic analysis that in many instances were previously impractical. To help its customers achieve and exploit advances in life science research, agricultural biotechnology, or Ag-Bio, and molecular diagnostics, Fluidigm provides robust systems that deliver high throughput and simpler workflows at decreased costs. Fluidigm microfluidic systems overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components onto a single microfabricated chip. Fluidigm technology enables its customers to perform and measure thousands of sophisticated biochemical reactions on samples smaller than the content of a single cell, while utilizing minute volumes of reagents and samples. Similarly, for next generation DNA sequencing, Fluidigm systems enable rapid preparation of multiple samples in parallel at low cost.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018